Razi Institute was represented by Ali Dr. Es-haghi, Director General, and Dr. Seyed Reza Banihashemi, Director R&D Department.

The meeting's agenda was packed with critical discussions aimed at addressing pressing challenges in vaccine accessibility. The first day featured the DCVMN General Assembly, exclusively for members. The second day discussed crucial topics such as regulatory harmonization and clinical development, which are essential for ensuring timely access to vaccines in Low-Income Countries (LICs) and Lower-Middle-Income Countries (LMICs). Additionally, discussions on innovations in financial mechanisms aimed at influencing universal coverage were a focal point.

On the third day, attendees engaged in special sessions covering the mRNA Tech-Transfer Program and Africa's manufacturing capacity mapping for 2024. The impact of climate change and the importance of environmental sustainability and achieving net-zero emissions were also key themes.

In a strategic move to strengthen partnerships, Razi Institute held a meeting with representatives from CanSinoBio, a prominent vaccine manufacturer, on the sidelines of the event. This collaboration underscores the institute's dedication to enhancing vaccine production capabilities and addressing global health challenges.